| Name | Title | Contact Details |
|---|---|---|
Tony Cheng |
Chief Data and Information Officer | Profile |
Jeremy Landis |
Chief Technology Officer | Profile |
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
New London Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New London Hospital is based in New London, NH. You can find more information on New London Hospital at www.newlondonhospital.org
Copies - FYI is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lake County Tribal Health Consortium is a Lakeport, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MPOWERHealth is dedicated to empowering better healthcare through innovative solutions for specialty physicians, hospitals and payors. Its services include an integrated physician network that supports collaboration between neuromusculoskeletal physicians to promote quality improvements; best-in-class neuromonitoring services for physicians, hospitals, health systems and medical facilities; and bundled solutions for payors that create direct access to the highest level of conservative spine care at a set cost. Based in Addison, Texas, MPOWERHealth serves more than 400 physicians, 55,000-plus patients and over 300 facilities in 24 states.